PMGC Holdings Inc. (NASDAQ:ELAB – Get Free Report) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totaling 81,359 shares, an increase of 109.4% from the December 15th total of 38,846 shares. Approximately 16.2% of the company’s shares are sold short. Based on an average daily trading volume, of 1,267,962 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily trading volume, of 1,267,962 shares, the days-to-cover ratio is currently 0.1 days. Approximately 16.2% of the company’s shares are sold short.
PMGC Trading Down 14.3%
NASDAQ:ELAB opened at $3.18 on Friday. PMGC has a twelve month low of $3.10 and a twelve month high of $398.86. The company has a market cap of $1.60 million, a price-to-earnings ratio of -0.05 and a beta of 0.67. The stock has a fifty day simple moving average of $13.34 and a 200-day simple moving average of $21.55.
PMGC (NASDAQ:ELAB – Get Free Report) last posted its quarterly earnings results on Friday, November 14th. The company reported ($19.80) EPS for the quarter. The firm had revenue of $0.29 million for the quarter.
Analyst Upgrades and Downgrades
Read Our Latest Report on ELAB
About PMGC
Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.
Further Reading
- Five stocks we like better than PMGC
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for PMGC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMGC and related companies with MarketBeat.com's FREE daily email newsletter.
